CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced that Mark Corrigan, President and CEO is scheduled to preside over the NASDAQ closing bell ceremony on Friday, September 17, 2010 at 4:00 p.m. to celebrate the Company’s recent name and ticker symbol change. The Company’s common stock began trading on the NASDAQ Global Market on Thursday, September 9, 2010 under the ticker symbol ZLCS. Interested parties may access the NASDAQ MarketSite webcam feed to view the ceremony live by launching this link, http://www.nasdaq.com/about/marketsitetowervideo.asx at 3:50 p.m.
